FindTrial
Sign In

Is ‘Enhanced recovery protocols’ feasible in cancer surgery

Are Enhanced recovery protocols feasible in cytoreductive surgery with heated intraperitoneal chemotherapy?: A prospective multicentre validation study - ERAS-HIPEC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/02/031151
Enrollment
500
Registered
2021-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C762- Malignant neoplasm of abdomen Health Condition 2: C269- Malignant neoplasm of ill-definedsites within the digestive system Health Condition 3: C569- Malignant neoplasm of unspecifiedovary Health Condition 4: C45-C49- Malignant neoplasms of mesothelial and soft tissue

Interventions

None listed

Sponsors

Geetu Prakash Bhandoria
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with malignancies of Gastrointestinal/Ovarian/Fallopian tube/Peritoneal origin undergoing cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy

Exclusion criteria

Exclusion criteria: 1. Unfit for surgery 2. Refusal to participate in study

Design outcomes

Primary

MeasureTime frame
1. Extent of adherence to ERAS protocols 2. Postoperative complications 3. Length of stayTimepoint: 30 days after surgery—

Secondary

MeasureTime frame
30 days postoperative mortalityTimepoint: 30 days after surgery—

Countries

India

Contacts

Public ContactGeetu Prakash Bhandoria

Command Hospital Kolkata

bhandoriageetu@gmail.com9913109759

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026